KolGene

Genetic Testing

Health Tech & Life Sciences
Non Active, Jul 2019 ceased to operate

Company Overview

Snapshot

Founded in January 2016 by Dan Faszczyk and Yonatan Levin, KolGene operates with 1–10 employees. The company has raised $1.1M across two funding rounds from three investors. In November 2016, KolGene secured funding from OurCrowd.

Business overview

KolGene provides a digital platform that streamlines the process of ordering genetic tests from laboratories globally. The company's core technology connects clinicians with a diverse range of genetic tests, enabling them to access necessary diagnostics for patients at competitive prices. KolGene operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Clinical Workflow, utilizing artificial intelligence and machine learning to enhance its web-based platform.

Strategic signal

In January 2018, KolGene launched its latest release, which automates hospital tracking for genetic test orders. This development signifies the company's commitment to improving clinical workflow efficiency and integrating its platform more deeply into healthcare systems. For investors, this indicates a strategic move towards enhancing product utility and potentially expanding market penetration within the hospital segment.

Company Intelligence Q&A

What is KolGene's primary offering?
KolGene provides a digital platform that allows clinicians to order genetic tests from various laboratories worldwide, aiming to make genetic diagnostics more accessible and affordable.
When was KolGene founded and by whom?
KolGene was founded in January 2016 by co-founders Dan Faszczyk and Yonatan Levin.
What was a key product development for KolGene in 2018?
In January 2018, KolGene released an update that automates the tracking of genetic test orders for hospitals, enhancing clinical workflow efficiency.
Which company partnered with KolGene in May 2017?
In May 2017, PreventionGenetics partnered with KolGene to provide clinicians worldwide with access to PreventionGenetics' test menu.
What was a significant early funding event for KolGene?
In November 2016, KolGene secured $1,000,000 in funding from OurCrowd.

External links